COMMUNIQUÉS West-GlobeNewswire

Scythian Biosciences Announces Appointment of Professor Michael Barnes as Chief Medical Officer
15/02/2018
- Influential voice in medical cannabis policy in Europe - A leading world authority in neurological rehabilitation TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the “ Company ” or “ Scythian [...]
CORRECTION - Shire Announces FDA Acceptance of sBLA for CINRYZE® for Pediatric Hereditary Angioedema Use
15/02/2018
**CORRECTION - Shire Announces FDA Acceptance of sBLA for CINRYZE ® (C1 esterase inhibitor [human]) for Pediatric Hereditary Angioedema Use FDA assigns an action date of June 20, 2018 If approved, CINRYZE will be the [...]
Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference
15/02/2018
YARDLEY, Pa., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive [...]
Epilepsy Foundation Pipeline Conference to Feature Winners of the SUDEP Challenge on Identifying Biomarkers Predicting Sudden Unexpected Death in Epilepsy (SUDEP)
15/02/2018
LANDOVER, Md., Feb. 15, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation Pipeline Conference will feature the winners of the SUDEP Institute’s 2 nd milestone of its fourth challenge , “Developing Predictive Biomarkers [...]
UPDATE - Intra-Cellular Therapies to Present at RBC Capital Markets 2018 Global Healthcare Conference
15/02/2018
NEW YORK, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ) a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results
15/02/2018
- GEN-009 neoantigen vaccine advancing to IND filing - - Balance sheet strengthened with $55m gross proceeds from January equity financing - - Conference call today at 9 am ET - CAMBRIDGE, Mass., Feb. 15, 2018 (GLOBE [...]
Extendicare Announces February 2018 Dividend of C$0.04 per Share
15/02/2018
MARKHAM, Ontario, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
15/02/2018
BOSTON, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK ), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Athenex Meets Enrollment Target for Oraxol Phase III Clinical Trial in Metastatic Breast Cancer
15/02/2018
BUFFALO, N.Y., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Athenex (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer [...]
Immunomedics to Participate in RBC Capital Markets 2018 Global Healthcare Conference
15/02/2018
MORRIS PLAINS, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will participate in [...]
Progressive Care to Accept Bitcoin for its Pharmacy Unit
15/02/2018
MIAMI, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces that its retail pharmacy will officially begin accepting Bitcoin payments. Customers [...]
Cytori Scleroderma Trial Data Presented at Systemic Sclerosis World Congress
15/02/2018
SAN DIEGO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today presented data from the U.S. 88 patient, 19 center, randomized, double blind, placebo-controlled [...]
Insmed to Host Fourth Quarter and Full Year 2017 Financial Results Conference Call on Friday, February 23, 2018
15/02/2018
BRIDGEWATER, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that it will [...]
Spectral Announces Health Canada Approval of Its Proprietary Stand-Alone Pump for CRRT and Hemoperfusion
15/02/2018
TORONTO, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Spectral Medical Inc., (TSX: EDT ), a Phase III company developing a treatment for patients with endotoxemic septic shock, today announced that Health Canada (HC) has approved [...]
Dr. Joseph DeSanto and BioCorRx Recovery Program Participant Appear on the TV Show, The Doctors
15/02/2018
ANAHEIM, CA, Feb. 15, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Dr. [...]
Cambrex to Present at the 2018 RBC Capital Markets Global Healthcare Conference
15/02/2018
EAST RUTHERFORD, N.J., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), a leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that [...]
Capital Senior Living Named One of the Top Senior Living Providers in J.D. Power Resident Satisfaction Survey
15/02/2018
DALLAS, Feb. 15, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE: CSU ), one of the nation’s largest operators of senior living communities, was recognized by J.D. Power, a global market [...]
RadNet, Inc. to Present at the RBC Capital Markets Healthcare Conference on February 21, 2018
15/02/2018
LOS ANGELES, Feb. 15, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Avid Bioservices Announces Pricing of Public Offering of Common Stock
15/02/2018
TUSTIN, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO ) (NASDAQ: CDMOP ) today announced the pricing of an underwritten public offering of 9,000,000 shares of its common stock at a price [...]

Pages